These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. Schaeffer AJ; Stuppy BA J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399 [TBL] [Abstract][Full Text] [Related]
43. Empiric antibiotics: selection and use in urology. Carson CC Contemp Urol; 1995 Mar; 7(3):36-7, 40-2, 44 passim. PubMed ID: 10150178 [No Abstract] [Full Text] [Related]
44. Management of urinary tract infections. Med Lett Drugs Ther; 1970 Jun; 12(12):49-51. PubMed ID: 5527415 [No Abstract] [Full Text] [Related]
45. Evaluation and therapy of urinary tract infection: a critique. Soderdahl DW Hawaii Med J; 1986 Sep; 45(9):306-10. PubMed ID: 3771203 [No Abstract] [Full Text] [Related]
47. [Nitrofurans: a modern treatment for uncomplicated urinary infections?]. Cahen P; Honderlick P Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843 [TBL] [Abstract][Full Text] [Related]
48. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)]. Wagenlehner E; Niemetz A; Naber G Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879 [TBL] [Abstract][Full Text] [Related]
49. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O; J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634 [TBL] [Abstract][Full Text] [Related]
50. [Direct cost of antibiotic therapy prescribed for nosocomial bacteremia. Prospective study during 6 months at a CHU (University Hospital Center)]. Daumal F; Etienne C; Votte P; Bou P; Canarelli B; Desablens F; Schmit JL; Eb F Pathol Biol (Paris); 1998 Jun; 46(6):470-5. PubMed ID: 9769884 [TBL] [Abstract][Full Text] [Related]
51. Transitional (intravenous to oral) antibiotic therapy. Quintiliani R; Grant E; Quintiliani R J Med Liban; 2000; 48(4):233-40. PubMed ID: 11214195 [TBL] [Abstract][Full Text] [Related]
57. Treatment of urinary tract infections in dogs and cats. Lees GE; Rogers KS J Am Vet Med Assoc; 1986 Sep; 189(6):648-52. PubMed ID: 3759631 [No Abstract] [Full Text] [Related]
58. Pharmacokinetic considerations in the treatment of urinary tract infections. Cunha BA; Comer JB Conn Med; 1979 Jun; 43(6):347-53. PubMed ID: 467046 [No Abstract] [Full Text] [Related]
59. [Clinical experimentation of a new antibiotic-azo dye combination (N4,N4-terephthalal-bis-[D-4-amino-3-isooxazolidone] + 2,6-diamino-3-phenylazo-pyridine hydrochloride) in urinary tract infections]. Zini S; Marcelli G Minerva Urol; 1965; 17(5):206-8. PubMed ID: 5323623 [No Abstract] [Full Text] [Related]
60. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Wagenlehner FM; Naber KG Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]